These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 21965843)

  • 41. Recent progress in melasma pathogenesis.
    Lee AY
    Pigment Cell Melanoma Res; 2015 Nov; 28(6):648-60. PubMed ID: 26230865
    [TBL] [Abstract][Full Text] [Related]  

  • 42. New oral and topical approaches for the treatment of melasma.
    Grimes PE; Ijaz S; Nashawati R; Kwak D
    Int J Womens Dermatol; 2019 Feb; 5(1):30-36. PubMed ID: 30809577
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Complex segregation analysis of facial melasma in Brazil: evidence for a genetic susceptibility with a dominant pattern of segregation.
    Holmo NF; Ramos GB; Salomão H; Werneck RI; Mira MT; Miot LDB; Miot HA
    Arch Dermatol Res; 2018 Dec; 310(10):827-831. PubMed ID: 30167816
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Melasma.
    Lee BW; Schwartz RA; Janniger CK
    G Ital Dermatol Venereol; 2017 Feb; 152(1):36-45. PubMed ID: 27589484
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effectiveness of a new cosmetic treatment for melasma.
    Berardesca E; Rigoni C; Cantù A; Cameli N; Tedeschi A; ; Laureti T
    J Cosmet Dermatol; 2020 Jul; 19(7):1684-1690. PubMed ID: 31746537
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Near-visible light and UV photoprotection in the treatment of melasma: a double-blind randomized trial.
    Castanedo-Cazares JP; Hernandez-Blanco D; Carlos-Ortega B; Fuentes-Ahumada C; Torres-Álvarez B
    Photodermatol Photoimmunol Photomed; 2014 Feb; 30(1):35-42. PubMed ID: 24313385
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Clinical and epidemiologic features of melasma: a multicentric cross-sectional study from India.
    Sarkar R; Jagadeesan S; Basavapura Madegowda S; Verma S; Hassan I; Bhat Y; Minni K; Jha A; Das A; Jain G; Arya L; Mandlewala Z; Bagadia J; Garg V
    Int J Dermatol; 2019 Nov; 58(11):1305-1310. PubMed ID: 31187480
    [TBL] [Abstract][Full Text] [Related]  

  • 48. New Protocol for Long-Term Results With a Multi-Pulse Nd:YAG Laser for Melasma Treatment: A Descriptive Cohort Study.
    Ocampo JCV; Ocampo SV; Vélez NC; Braun M
    J Drugs Dermatol; 2021 Feb; 20(2):150-154. PubMed ID: 33538564
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Melasma: a review.
    Victor FC; Gelber J; Rao B
    J Cutan Med Surg; 2004; 8(2):97-102. PubMed ID: 15685388
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Efficacy of 694-nm Q-switched ruby fractional laser treatment of melasma in female Korean patients.
    Jang WS; Lee CK; Kim BJ; Kim MN
    Dermatol Surg; 2011 Aug; 37(8):1133-40. PubMed ID: 21585597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Melasma in men. A clinical and histologic study.
    Vázquez M; Maldonado H; Benmamán C; Sánchez JL
    Int J Dermatol; 1988; 27(1):25-7. PubMed ID: 3346120
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Effect of 82% Lactic Acid in Treatment of Melasma.
    Singh R; Goyal S; Ahmed QR; Gupta N; Singh S
    Int Sch Res Notices; 2014; 2014():407142. PubMed ID: 27355080
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Melasma: How hormones can modulate skin pigmentation.
    Filoni A; Mariano M; Cameli N
    J Cosmet Dermatol; 2019 Apr; 18(2):458-463. PubMed ID: 30779300
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Association of melasma with thyroid autoimmunity and other thyroidal abnormalities and their relationship to the origin of the melasma.
    Lutfi RJ; Fridmanis M; Misiunas AL; Pafume O; Gonzalez EA; Villemur JA; Mazzini MA; Niepomniszcze H
    J Clin Endocrinol Metab; 1985 Jul; 61(1):28-31. PubMed ID: 3923030
    [TBL] [Abstract][Full Text] [Related]  

  • 55. CD4, IL-17, and COX-2 Are Associated With Subclinical Inflammation in Malar Melasma.
    Rodríguez-Arámbula A; Torres-Álvarez B; Cortés-García D; Fuentes-Ahumada C; Castanedo-Cázares JP
    Am J Dermatopathol; 2015 Oct; 37(10):761-6. PubMed ID: 26381025
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Heterogeneous Pathology of Melasma and Its Clinical Implications.
    Kwon SH; Hwang YJ; Lee SK; Park KC
    Int J Mol Sci; 2016 May; 17(6):. PubMed ID: 27240341
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Oral Tranexemic Acid With Triple Combination Cream (Flucinolone+Hydroquinone+Tretinoin) Versus Triple Combination Cream Alone In Treatment Of Melasma.
    Basit A; Rahman A; Uddin R
    J Ayub Med Coll Abbottabad; 2021; 33(2):293-298. PubMed ID: 34137548
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Role of fibroblast-derived factors in the pathogenesis of melasma.
    Byun JW; Park IS; Choi GS; Shin J
    Clin Exp Dermatol; 2016 Aug; 41(6):601-9. PubMed ID: 27416970
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Therapeutical approaches in melasma.
    Prignano F; Ortonne JP; Buggiani G; Lotti T
    Dermatol Clin; 2007 Jul; 25(3):337-42, viii. PubMed ID: 17662899
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The stepwise approach to the treatment of melasma.
    Perez MI
    Cutis; 2005 Apr; 75(4):217-22. PubMed ID: 15916218
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.